TrialCancer chemotherapy and pharmacology2022

A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL).

Suja Johnson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.